OM
Outset Medical
Stock NYSE – Stock Market Prices, News & Analysis
Outset Medical Inc est une entreprise médicale qui se concentre sur la technologie innovante de dialyse pour les soins des reins.
Outset Medical
OM
Outset Medical Inc est une entreprise médicale qui se concentre sur la technologie innovante de dialyse pour les soins des reins.
Price history of Outset Medical
Price history of Outset Medical
Performance & Momentum
Outset Medical's Target Cut, New Tablo FDA Approved
Outset Medical (NASDAQ: OM) had its target price lowered from $14 to $8 by Stifel, which remains bullish with a buy rating, citing short-term pressures in the MedTech sector. Meanwhile, the company secured FDA approval for the next-generation Tablo hemodialysis system, the first to meet strict cybersecurity standards, with a planned launch in Q2 2026. These factors reflect a balance between financial challenges and promising technological advancements.
Similar stocks to Outset Medical
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
